Relationship of adiponectin with metabolic syndrome components in pubertal children

Atherosclerosis

Volumn 216, Issue 2, 2011, Pages 467-470

  Riestra, Pía ^a   García Anguita, Alicia ^a   Lasunción, Miguel A ^b   Cano, Beatriz ^a   de Oya, Manuel ^a   Garcés, Carmen ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Adiponectin; HDL cholesterol; HDL phospholipids; Insulin; Pubertal children

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBERTY; SCHOOL CHILD;

ADIPONECTIN; ADOLESCENT; ANTHROPOMETRY; BLOOD PRESSURE; CHILD; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; PHOSPHOLIPIDS;

EID: 79958014229     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.02.031     Document Type: Article

References (40)

1. Havel P.J. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 2002, 13:51-59.
2. Ahima R.S., Qi Y., Singhal N.S., Jackson M.B., Scherer P.E. Brain adipocytokine action and metabolic regulation. Diabetes 2006, 55:S145-S154.
3. Yang W.S., Lee W.J., Funahashi T., et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002, 10:1104-1110.
4. Hara T., Fujiwara H., Shoji T., et al. Decreased plasma adiponectin levels in young obese males. J Atheroscler Thromb 2003, 10:234-238.
5. Stefan N., Stumvoll M. Adiponectin: its role in metabolism and beyond. Horm Metab Res 2002, 34:469-474.
6. Spranger J., Kroke A., Mohlig M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361:226-228.
7. Kadowaki T., Yamauchi T., Kubota N., et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
8. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
9. Berg A.H., Combs T.P., Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002, 13:84-89.
10. Lihn A.S., Pedersen S.B., Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005, 6:13-21.
11. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57-58.
12. Han S.H., Sakuma I., Shin E.K., Koh K.K. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis 2009, 52:126-140.
13. Pishon T., Girman C.J., Hotamisligil G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
14. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
15. Yamamoto Y., Hirose H., Saito I., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci 2002, 103:137-142.
16. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence of independent roles of age and sex. Diabetologia 2003, 46:459-469.
17. Tschritter O., Fritsche A., Thamer C., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003, 52:239-243.
18. Altinova A.E., Toruner F., Bukan N., et al. Decreased plasma adiponectin is associated with insulin resistance and HDL-C in overweight subjects. Endocrinol J 2007, 54:221-226.
19. Goropashnaya A.V., Herron J., Sexton M., et al. Relationships between plasma adiponectin and body fat distribution, insulin sensitivity and plasma lipoproteins in Alaskan Yupóik Eskimos. The Center for Alaska Native Health Study. Metabolism 2009, 58:22-29.
20. Chu N.F., Shen M.H., Wu D.M., Lai C.J. Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children. Obes Res 2005, 13:2014-2020.
21. Kettaneh A., Heude B., Oppert J.M., et al. Serum adiponectin is related to plasma high-density lipoprotein cholesterol but not to plasma insulin-concentration in healthy children: the FLVS II study. Metabolism 2006, 55:1171-1176.
22. Winer J.C., Zern T.L., Taksali S.E., et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 2006, 91:4415-4423.
23. Shaibi G.Q., Cruz M.L., Weigensberg M.J., et al. Adiponectin independently predicts metabolic syndrome in overweight Latino youth. J Clin Endocrinol Metab 2007, 92:1809-1813.
24. Gilardini L., Mcternan P.G., Girola A., et al. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis 2006, 189:401-407.
25. Calcaterra V., De Amici M., Klersy C. Adiponectin, IL 10 and metabolic syndrome in obese children and adolescents. Acta Biomed 2009, 80:117-123.
26. Schneider J.G., von Eynatten M., Schiekofer S., Nawroth P.P., Dugi K.A. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 2005, 28:2181-2186.
27. Clarenbach J.J., Vega G.L., Adams-Huet B., et al. Variability in post heparin hepatic lipase activity is associated with plasma adiponectin levels in African Americans. J Investig Med 2007, 55:187-194.
28. Lamarche B., Uffelman K.D., Carpentier A., et al. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 1999, 103:1191-1199.
29. Duong M., Psaltis M., Rader D.J., et al. Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids. Biochemistry 2003, 42:13778-13785.
30. Shklyaev S., Aslanidi G., Tennant M., et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci U S A 2003, 100:14217-14222.
31. Botma G.J., van Deursen D., Vieira D., et al. Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression. Atherosclerosis 2005, 179:61-67.
32. Fournier N., de la Llera Moya M., Burkey B.F., et al. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J Lipid Res 1996, 37:1704-1711.
33. Jian B., de la Llera-Moya M., Royer L., et al. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J Lipid Res 1997, 38:734-744.
34. Naito H.K., Greenstreet R.L., David J.A., et al. HDL-cholesterol concentration and severity of coronary atherosclerosis determined by cine-angiography. Artery 1980, 8:101-112.
35. Fournier N., Paul J.L., Atger V., et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997, 17:2685-2691.
36. Fournier N., Atger V., Cogny A., et al. Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis 2001, 157:315-323.
37. Nishizawa H., Shimomura I., Kishida K., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51:2734-2741.
38. Combs T.P., Berg A.H., Rajala M.W., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003, 52:268-276.
39. Böttner A., Kratzsch J., Müller G., et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004, 89:4053-4061.
40. Lambert M., O'Loughlin J., Delvin E.E., et al. Association between insulin, leptin, adiponectin and blood pressure in youth. J Hypertens 2009, 27:1025-1032.